Reality Facial volume loss follows rapid weight loss regardless of the method used, so changes attributed to the drug are actually a consequence of the speed and magnitude of the loss
Glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (Ozempic, Wegovy), and tirzepatide (Mounjaro, Zepbound), which is a dual GIP/GLP-1 receptor agonist, influence blood sugar regulation and appetite
While the relationship between GLP-1 receptor agonists and psychiatric symptoms remains under investigation, some reports have suggested potential mood changes in susceptible individuals
And every minute that vial sits on a countertop instead of a refrigerator shelf, you are gambling with your investment
So when patients are placed on severe calorie-restrictive diets, this will impact their hair growth," Dr